Cargando…
The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis
BACKGROUND: Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS). Despite improvements of immunomodulatory therapies in relapsing–remitting MS, the pathomechanisms of progressive disease are poorly understood and therapeutically addressed to date. A pat...
Autores principales: | Diebold, Martin, Derfuss, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407165/ https://www.ncbi.nlm.nih.gov/pubmed/30873219 http://dx.doi.org/10.1177/1756286419833574 |
Ejemplares similares
-
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS
por: Zimmermann, Maria, et al.
Publicado: (2015) -
Endogenous retroviruses: are they the cause of multiple sclerosis?
por: Fujinami, Robert S, et al.
Publicado: (1999) -
Analysis of Human Endogenous Retrovirus Expression in Multiple Sclerosis Plaques
por: Bhetariya, PJ, et al.
Publicado: (2017) -
Endogenous retroviruses and multiple sclerosis–new pieces to the puzzle
por: Nissen, Kari K, et al.
Publicado: (2013) -
Genetic Determinants of Antibody Levels in Cerebrospinal Fluid in Multiple Sclerosis: Possible Links to Endogenous Retroviruses
por: Emmer, Alexander, et al.
Publicado: (2018)